New shot aims to shield cancer patients from Chemo's hidden danger
NCT ID NCT07187908
Summary
This study is testing a new injection called efbemalenograstim alfa-vuxw to see if it can prevent a dangerous side effect of chemotherapy called febrile neutropenia. Febrile neutropenia is a severe drop in infection-fighting white blood cells, which can lead to life-threatening infections. The trial will enroll over 1,000 adults with solid tumors who are at high or intermediate risk for this complication during their chemotherapy treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY/SECONDARY PREVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Henan cancer hospital
RECRUITINGZhengzhou, Henan, 450003, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.